CVR MEDICAL’S CAROTID STENOTIC SCAN DISPLAYED AT CES 2017

CVR MEDICAL’S CAROTID STENOTIC SCAN DISPLAYED AT CES 2017
CVR MEDICAL’S CAROTID STENOTIC SCAN DISPLAYED AT CES 2017

$CRRVF

CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) will be joining Energous Corporation (NASDAQ: WATT) at the upcoming CES, one of the premier, annual emerging technology events in North America.

Energous will be demonstrating its device’s applications with CVR’s “Carotid Stenotic Scan (CSS).”

CVR Medical Corp., in conjunction with CVR Global Inc, has patented and developed a sub-sonic sound analysis technology to detect and diagnose atherosclerosis and stenosis within the human arterial system. The first application of the technology, the CSS, is a non-invasive medical device designed to measure carotid arterial stenosis.

Energous Corporation’s WattUp® technology is an RF-based, revolutionary wire-free charging technology. WattUp receiver technology will be integrated into CVR’s Carotid Stenotic Scan’s sensor array, while the cart will contain WattUp transmitter as part of the charging cradle.

CVR Medical CEO Peter Bakema states, “As we’ve developed our own technology with the potential for significant impact, we’ve kept our eyes open for those who share our core beliefs of providing consumers with efficiency and value. Energous presents the sort of partnership opportunity that can take our device to the next level, and we look forward to exploring that at CES.”

For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.
ON BEHALF OF THE BOARD:
(signed) “Peter Bakema”
CEO, President & Director

For further information contact:
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH